Variantyx is a Biotech company based in Framingham. It has raised $125M in total funding. Latest round: Growth.
Variantyx is a Biotech company based in Framingham. Variantyx has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in April 2024. The round record for Variantyx runs through 2024; nothing later has been disclosed. Investors on record include Peregrine Ventures, Pitango HealthTech, New Era Capital Partners, Bosch Ventures, 20/20 HealthCare Partners. 5 distinct backers are named across the disclosed rounds.
Round data for Variantyx is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Framingham and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026